Preserving Muscle During Weight Loss When losing weight, especially with GLP-1 medications, the goal is to shed fat, not muscle
Over time, pharmacological engineering enabled: Short-acting injectables (e.g., exenatide) Long-acting once-weekly injectables (liraglutide, semaglutide) Multi-target incretin therapies (tirzepatide) Oral peptide formulations and now oral small molecules The most recent breakthrough is the development of orally available GLP-1 receptor agonists, including: Orforglipron (Lilly) Elecoglipron (AstraZeneca) These compounds eliminate the need for injection and could dramatically expand accessibility and adherence in obesity and diabetes populations
Unlike Noom Weight, which focuses on behavioral changes through daily lessons, food tracking, and coaching, Noom Med incorporates medical assessments, clinician support, and access to GLP-1 weight loss medications , like GLP-1 receptor agonists (semaglutide, tirzepatide) or oral medications like metformin
Hypersensitivity reactions may manifest as urticaria, angioedema, bronchospasm, or anaphylaxis, and any previous allergic reaction to tirzepatide or related GLP-1 receptor agonists should be considered an absolute contraindication
What foods protect the brain the most
